Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

ACTHar in the Treatment of Lupus Nephritis

Phase 4

Completed

Conditions: Lupus Nephritis

Interventions: Drug: CellCept
Drug: ACTHar gel

First Posted Date: 2014-08-27

Last Posted Date: 2024-07-22

Lead Sponsor: Columbia University

Target Recruit Count: 8

Registration Number: NCT02226341

Locations: 🇺🇸
Columbia University - Herbert Irving Pavilion, New York, New York, United States

Bone Mass and Strength After Kidney Transplantation

Phase 2

Completed

Conditions: End Stage Renal Disease
Fractures
Kidney Transplantation
Bone Loss
Vascular Calcifications

Interventions: Drug: Vitamin D3
Drug: Placebo
Drug: Calcitriol

First Posted Date: 2014-08-25

Last Posted Date: 2022-04-15

Lead Sponsor: Columbia University

Target Recruit Count: 67

Registration Number: NCT02224144

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy

Phase 2

Completed

Conditions: Uveal Melanoma

Interventions: Drug: Crizotinib

First Posted Date: 2014-08-22

Last Posted Date: 2023-12-06

Lead Sponsor: Columbia University

Target Recruit Count: 34

Registration Number: NCT02223819

Locations: 🇺🇸
Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States
🇺🇸
Columbia Univeristy Medical Center, New York, New York, United States
🇺🇸
The Ohio State University, Columbus, Ohio, United States

and more 1 locations

Bone Remodeling After Immediate Implant Placement With and Without Bone Grafting

Not Applicable

Completed

Conditions: Tooth Loss

Interventions: Device: BioOss Collagen at the time of implant placement

First Posted Date: 2014-06-25

Last Posted Date: 2019-06-13

Lead Sponsor: Columbia University

Target Recruit Count: 32

Registration Number: NCT02174198

Locations: 🇺🇸
Columbia University, College of Dental Medicine, New York, New York, United States

PrEPared and Strong: Clinic-Based PrEP for Black MSM

Phase 4

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: Enhanced PrEP Adherence
Behavioral: Standard PrEP Adherence

First Posted Date: 2014-06-19

Last Posted Date: 2018-05-17

Lead Sponsor: Columbia University

Target Recruit Count: 204

Registration Number: NCT02167386

Locations: 🇺🇸
Harlem Prevention Center, New York, New York, United States
🇺🇸
Harlem United, New York, New York, United States

Prenatal Microarray Follow-Up Study

Completed

Conditions: Genetic Diseases

Interventions: Other: 3-year follow-up

First Posted Date: 2014-06-11

Last Posted Date: 2019-03-25

Lead Sponsor: Columbia University

Target Recruit Count: 184

Registration Number: NCT02160938

Locations: 🇺🇸
Mt. Sinai Medical Center, New York, New York, United States
🇺🇸
Center for Fetal Medicine, Los Angeles, California, United States
🇺🇸
North Shore LIJ, Manhasset, New York, United States

and more 6 locations

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

Phase 4

Completed

Conditions: Implant or Graft; Rejection

Interventions: Drug: Tacrolimus
Drug: Belatacept
Drug: Mycophenolate
Drug: rATG
Drug: Methylprednisolone
Procedure: Renal transplant

First Posted Date: 2014-06-02

Last Posted Date: 2021-02-10

Lead Sponsor: Columbia University

Target Recruit Count: 57

Registration Number: NCT02152345

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Boceprevir in End Stage Renal Disease (ESRD)

Not Applicable

Withdrawn

Conditions: End Stage Renal Disease
Hepatitis C Infection

Interventions: Drug: P-IFN alfa 2a
Drug: P-IFN alfa 2b
Drug: Ribavirin
Drug: Boceprevir

First Posted Date: 2014-04-14

Last Posted Date: 2015-09-23

Lead Sponsor: Columbia University

Registration Number: NCT02112630

Selenium in Mild Thyroid Eye Disease in North America

Phase 3

Withdrawn

Conditions: Thyroid Associated Ophthalmopathies

Interventions: Drug: Sodium selenate
Dietary Supplement: Sugar pill

First Posted Date: 2014-04-14

Last Posted Date: 2021-08-18

Lead Sponsor: Columbia University

Registration Number: NCT02112643

A Pilot Study Using Text Messaging to Communicate With Adolescent Females in the Pediatric Emergency Department

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Other: Text Messaging Intervention
Other: Standard Referral

First Posted Date: 2014-03-21

Last Posted Date: 2017-01-20

Lead Sponsor: Columbia University

Target Recruit Count: 100

Registration Number: NCT02093884

Locations: 🇺🇸
Morgan Stanley Children's Hospital Emergency Department, Manhattan, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy